A spontaneously EBV transformed follicular lymphoma (FL) cell line, Tat-1, was established from the lymph node biopsy specimen of a patient with B cell FL, grade 1 in transformation to high grade disease. Tat-1 cells expressed lymphoid markers and developed tumor masses in immunodeficient mice. Bcl-2, Bcl-X L , Bax and p53 protein expression was revealed by Western blotting. Flow cytometric analysis confirmed P-gp expression. Cytogenetically, the Tat-1 cell line showed identical chromosomal alterations to that of the initial biopsy specimen, among which the most notable were the t(14;18) typical of FL and additional abnormalities involving chromosomes 1, 8 and 13. Multicolor FISH analysis delineated all abnormalities, including a t(1p;8q), a der(8)(8q24::14q32::18q21) and a der(13)(13q32::8q24::14q32::18q21). Further FISH investigations using a locus-specific probe cocktail containing c-myc, IgH and bcl-2 revealed fusion of these three loci on the derivatives 8 and 13, in addition to the derivative 14 IgH/bcl-2 fusion and an extra copy of c-myc on derivative chromosome 1. These results demonstrate an additional example of the deregulation of bcl-2 and c-myc expression through recombination with a single IgH enhancer region. The unusual molecular features of the Tat-1 cell line render it a unique tool for studies focused on cytogenetic alterations, expression of multidrug resistance phenotype and expression of anti-apoptotic proteins in FL.
Introduction
Low-grade follicular lymphoma (FL) represents one of the most common subtypes of B cell non-Hodgkin's lymphomas (NHL). [1] [2] [3] The disease is initially characterized by a clinically indolent course followed by conversion into more aggressive disease that is typically insensitive to standard therapeutic regimens. Recent cytogenetic, molecular genetic and histopathologic studies have provided insight into pathophysiological mechanisms involved in the development and progression of lymphomas. [4] [5] [6] [7] FL is characterized by the chromosomal translocation t(14;18)(q32;q21) or variant in up to 85% of cases. 8, 9 The t(14;18) induces deregulated expression of the bcl-2 gene, 10 but additional mutations are required to establish a fully malignant phenotype. 11 The various patterns of clinical behavior, and in particular the transformation to more aggressive disease, may be directly influenced by the secondary genetic changes which are evident in the great majority of cases at diagnosis and become more numerous during disease progression. [12] [13] [14] [15] [16] In order to establish the role of specific genes or proteins in low-grade NHL disease progression and to provide reliable functional correlations with response to treatment, sufficient numbers of viable lymphoma cells derived from patient specimens are required. Given that primary cultures of lymphoid tumors typically survive for only a matter of days, phenotypic and functional comparisons will rely mainly on access to stable cultures of lymphoma cells that exhibit distinctive genetic and phenotypic characteristics. 17, 18 For example, the establishment of cell lines demonstrating bcl-2 gene rearrangement and elevated Bcl-2 protein expression has helped to reveal the importance of anti-apoptotic mechanisms in the pathogenesis of low-grade NHL. 19 Also, cell lines exhibiting dual B/T phenotype and gene rearrangement have raised questions regarding the restriction of several antigens normally associated with B cell and T cell lineage, as well as the correlation of phenotype with gene rearrangement data. 20 In this context we report here the initial characterization of a new cell line, Tat-1, generated from a transformed grade 1 FL demonstrating Burkitt-like histology.
Materials and methods

Chemicals
Valspodar, SDZ PSC-833 [(3′-keto-Bmt 1 )- (Val   2   ) -cyclosporin], (Val) was a gift from Novartis Canada (Dorval, Canada). Doxorubicin hydrochloride for injection, USP (Dox) was obtained from Faulding Canada (Vaudreuil, Canada). Vincristine sulphate for injection, USP (Vin) was purchased from Pharmacia (Piscataway, NJ, USA). Cisplatin (Cis) was obtained from Bull Laboratories (Australia). 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyl tetrazolium bromide (MTT) and dimethylsulphoxide (DMSO) were purchased from Sigma Chemical (St Louis, MO, USA)
Processing of NHL clinical specimen
Sterile tissue was obtained from an axillary lymph node biopsy 4 years after the initial diagnosis of FL grade 1 subtype. A cell suspension was prepared by mechanical teasing and enriched for mononuclear cells by Ficoll-Isopaque density gradient centrifugation. A 2 × 10 6 cells/ml cell suspension in RPMI 1640 with 20% FBS (HyClone Laboratories, Vancouver, Canada), l-glutamine and antibiotics (StemCell Technologies, Vancouver, Canada), was placed in culture flasks (Falcon, Becton Dickinson, Franklin Lakes, NJ, USA) containing an irradiated confluent monolayer of 3T3 murine fibroblasts and incubated at 37°C in a humidified atmosphere of 5% CO 2 .
The morphologic appearance of the cell line was assessed on cytocentrifuge preparations stained with modified WrightGiemsa stain. Growth characteristics as well as the effect of interleukins IL-2, IL-4, IL-6 (Gibco BRL, Grand Island, NY, USA) on cell growth were evaluated from cell growth curves obtained by routine cell counting using an automatic cell counter (Coulter, Hialeah, FL, USA).
EBV detection
EBV infection was determined by PCR using primers specific for the BamH1W promoter site. In brief, DNA was extracted using the Puregene DNA isolation method (Gentra Systems, Minneapolis, MN, USA). The oligonucleotide primer sequences were designed in-house and synthesized by the Nucleic Acid/Protein Service Unit, University of British Columbia (Vancouver, Canada). The forward and reverse primer sequences, 5′-3′ were gccaggagtccacacaaatgta and ccagggccttcacttcggtc, respectively. Approximately 500 ng of template was amplified, using Taq polymerase (Perkin-Elmer, Missisauga, Ontario, Canada) and stock buffer, for 94°C × 5 min followed by 30 cycles of 94°C × 1 min, 60°C × 2 min, 72°C × 3 min, and a final extension of 72°C × 15 min. The DNA was visualized by ethidiumbromide on a 2% agarose gel.
Immunophenotyping
Cell surface antigen expression was studied by flow cytometry on an EPICS XL-mLC flow cytometer. Briefly, 50 l of a cell suspension (6 × 10 6 cells/ml in PBS) was incubated with 10 l of antibody (used in concentrations commercially supplied) for 30 min at 4°C and analyzed by flow cytometry. The antibody conjugates ((fluorescein isothiocyanate (FITC) and Rphycoerythrin-cyanin 5 (RPE-Cy5)) used in analyses are described in Table 1 . Off-line data analysis was performed 
Traditional and molecular cytogenenetic analysis
Chromosome analysis was performed using standard 24 h culture and harvest procedures and G-banding. The karyotype was described according to the International System for Human Cytogenetic nomenclature (ISCN) 1995. 21 MFISH analysis for 24-color karyotyping was performed according to the manufacturer's protocols (Metasystems, Altlussheim, Germany). For locus-specific FISH analysis a three-color probe cocktail was prepared by the addition of 1 g Cy5 (Amersham-Pharmacia) direct labeled c-myc probe (YAC 934E1) to 1 l Vysis dual-color IgH/bcl-2 probe (Vysis, USA). Probe-labeling, denaturation, hybridization and post-hybridization was performed according to the Vysis protocols.
Transplantation into immunodeficient mice
Six-to eight-week-old male Taconic RAG-2 knockout mice were inoculated with 1 × 10 6 or 5 × 10 6 cells (three mice per group). Tumorigenicity was estimated by observing animals for signs of stress, survival and evidence of solid tumor growth. Femur bone marrow, blood, lymph nodes, spleen, liver, lungs and kidneys were collected postmortem for macroscopic and histologic signs of tumor dissemination.
Leukemia
P-gp detection and Dox uptake assay
P-gp expression was studied by flow cytometry direct immunofluorescence analysis using phycoerythryn-conjugated anti-P-glycoprotein monoclonal antibodies clone 15D3 (Becton Dickinson, CA, USA). Staining was performed according to the manufacturer's protocol. Two strains of human breast carcinoma cell line MDA 435 LCC6 wild and LCC6 mdr-1 (transfected with mdr-1) were kindly provided by Dr R Clarke (Georgetown University Medical School, Washington, DC, USA) and used as negative and positive controls, respectively.
Flow cytometric studies were conducted to measure the kinetics of Dox uptake by individual cells as described previously. 22 Briefly, 1 × 10 6 cells/ml (viability Ͼ90%) suspensions were exposed to 10 m of Val for 2 h prior to incubation with 5 and 50 m Dox. Aliquots of the samples at intervals of 30 and 60 min were subjected to flow cytometric analysis (flow rate 500 cells/s). Dox fluorescence emission was filtered through a 550-nm long pass filter.
Cytotoxicity assay
The microculture tetrazolium-based cytotoxicity assay 22, 23 was utilized to assess chemosensitivity of the primary lymphoma cells and the established cell line. The anticancer drug concentration required to cause 50% tumor cell growth inhibition (IC50) was determined from a linear regression curve (plot of % relative viable cells vs log 10 drug concentration) of the data from at least triplicate analyses.
Statistical analysis was performed using paired Student's t-test for grouped data. In all cases a P value Ͻ0.05 was considered statistically significant.
Bcl-2, Bax, Bcl-X, and p53 detection by Western blotting
Western blotting was performed according to standard protocols. 24 The following antibodies were used for these analyses: monoclonal anti-human mouse anti-Bcl-2 (1:3333 dilution), anti-Bax (1:500 dilution), anti-actin (1:3333 dilution), polyclonal anti-human rabbit anti-Bcl-X (1:500 dilution), all of which antibodies were obtained from Santa Cruz Biotechnology (Santa Cruz, CA, USA), and monoclonal anti-human mouse anti-p53 antibodies, clone DO7 (1:100 dilution), purchased from DAKO (Carpinteria, CA, USA). Immunoreactivity was detected by 1 h incubation with 0.3 g/ml rabbit antimouse IgG-HRP conjugates or goat anti-rabbit IgG-HRP conjugates obtained from Promega (Madison, WI, USA). Specific complexes were detected by the ECL Plus chemiluminescence detection kit according to the manufacturer's recommendations (Amersham Pharmacia Biotech, Buckinghamshire, UK). K-562 cell line was obtained from ATCC (VA, USA) and DOHH-2 cell line was a generous gift from Gentra.
Results
Case report and histopathology of the tumor
The original lymph node biopsy in 1994 revealed FL, grade 1 subtype. Staging bone marrow examination showed paratrabecular infiltrates of small cleaved lymphocytes, thus establishing stage IV lymphoma. The patient, a 57-year-old Caucasian female, was given single agent chemotherapy of low-dose chlorambucil (6 mg daily) for 5 months and obtained a satisfactory response. Four years later after initial treatment the patient relapsed and a repeat right axillary lymph node biopsy was performed because of an enlarging mass at this site. The histologic examination revealed a composite histology with a background of follicular small-cleaved cells as well as large confluent masses of Burkitt-like cells, consistent with transformation to a high-grade NHL. Both small-cleaved cells of the neoplastic follicles and the Burkitt-like cells strongly expressed Bcl-2 protein. The patient underwent three cycles of combined chemotherapy with Dox, cyclophosphamide, Vin and prednisone (ACOP-12) without success and died from progressive lymphoma within 4 months.
Morphologic features, growth characteristics, immunophenotype and tumorigenicity
The Tat-1 cell line has been maintained in a state of continuous proliferation for 24 months. After 1 year in culture (RPMI 
Figure 3
Cell karyotype data on the lymphoma clinical specimens and the established Tat-1 cell line. Arrows show pathways of clonal evolution of the mainline and the sidelines.
Leukemia 1640 culture medium containing 20% FBS) the morphology of the lymphoma cells resembled that of the primary tumor cells (Figure 1a) . Most of the cells exhibited a uniform round shape, intermediate size and formed loose floating aggregates in liquid culture. The cell line was shown to harbor EBV genome using PCR (data not shown). It was shown to be negative for mycoplasma contamination by conventional microbiological culture method. The doubling time was 72 h for cells seeded at 0.2-0.5 × 10 6 cells/ml. Growth stimulation was observed in cultures supplemented with IL-2 or IL-4, while no effect was detected in cultures supplemented with IL-6 at the applied concentrations (Figure 2) . Heterotransplantability was evaluated using a 6-month cell culture. All mice injected subcutaneously (s.c.) with 5 × 10 6 cells exhibited tumors approximately within 9 weeks after cell inoculation. From these tumors small pieces or isolated tumor cells were re-injected s.c. into healthy animals. Visible histologically confirmed tumors developed in 4 weeks (Figure 1b) . Sub-lines of the Tat-1 tumors obtained after two in vivo passages displayed a gradual reduction in the expression of CD20 and FMC-7 antigens (Table 1) . Post-mortem macroscopic and histologic examination of animals did not reveal any signs of tumor dissemination.
Cytogenetic characteristics and molecular cytogenetic analysis of the Tat-1 cell line
Chromosomal analysis of the Tat-1 cell line revealed a complex abnormal karyotype identical to the dominant sideline found in the progressed lymphoma clinical specimen (Figure 3 ). The t(14;18) of FL was found as well as a der(1)t(1p;8q), an add(8)(24) and a der(13)t(13q24::8q::?). The complete karyotype is shown in Figure 4a . Cytogenetic analy- sis of the clinical sample and the established cell line confirmed that no chromosomal aberrations have been acquired or lost by Tat-1 cells during the culture period. Multicolor FISH (MFISH) analysis of Tat-1 by 24-color karyotyping was undertaken to delineate all chromosomal rearrangements and marker chromosomes. The balanced and unbalanced translocations identified by G-banding were confirmed. In addition, the add(8) and der(13) were shown to be complex translocations der(8)(8pter → 8q24::14q32::18q21 → 18qter) and der(13)(13pter → 13q24::8q24::14q32::18q21 → 18qter), respectively. A detailed description of the MFISH karyotype is shown in Figure 4b . FISH analysis using the three-color probe cocktail containing c-myc, IgH and bcl-2 revealed co-localization of these three loci on both the add(8q) and the der(13) chromosomes in addition to the IgH/bcl-2 fusion on the der(14)t(14;18) ( Figure 5 ). Unrearranged copies of c-myc were evident on the der(1)t(1p;8q) and the residual normal 8; an unrearranged copy of IgH was evident on the normal 14 and there were two normal copies of bcl-2 on the two normal 18 chromosomes. The breakpoint of bcl-2 in the patient was in the MBR cluster as detected by PCR analysis (data not shown). A der(18)t(14;18) was not found in this karyotype. In total there were four copies of c-myc (two normal, two combined with IgH/BCL2) four copies of IgH (one normal, one IgH/bcl-2 and two c-myc/IgH/bcl-2) and five copies of bcl-2 (two normal, one IgH/bcl-2 and two cmyc/IgH/bcl-2.
Cytotoxicity and drug uptake experiments
The chemosensitivity of the primary tumor cells and the established Tat-1 cell line to Dox is shown in Figure 6a . (Figure 6b ). As Tat-1 cells appear to be positive for P-gp protein expression we studied the effect of Val, an effective modulator of the P-gp protein activity, on Dox and Vin cytotoxicity. Both drugs are known to be substrates for P-gp and are often affected by the multidrug resistance phenotype. 16 Surprisingly, neither continuous nor pulsed treatment of Tat-1 cells with active concentration of Val revealed any notable changes in cell sensitivity to either drug (Figure 6c) . Also, Dox uptake in Tat-1 cells was found not to be affected by 2 h preexposure to Val. In comparison, MDA435-LCC6 mdr-1 demonstrated a distinctive increase of the intracellular Dox-related fluorescence indicating complete P-gp blockade by this agent under the same assay conditions. This effect increased after 60 min exposure to Dox (data not shown).
P-gp, Bcl-2, Bcl-X, Bax and p53 protein expression
Tat-1 cells demonstrated elevated levels of P-gp protein expression when compared with well-characterized positive and negative control breast cancer cell lines. The mean fluorescence intensity of the Tat-1 cells was five-fold higher than that seen for P-gp-negative MDA435/LCC6 wild cells. This compared to the 10-fold elevated mean fluorescence intensity observed for the mdr-1 transfected MDA435/LCC6 mdr-1 cell line (data not shown).
The expression of 26 kda Bcl-2 protein was higher in Tat-1 cells compared with the Bcl-2 over-expressing DOHH-2 transformed FL cell line (Figure 7 ). Significant levels of Bcl-X protein were detected using anti-Bcl-X SL antibody. Although this antibody does not discriminate between Bcl-X S and Bcl-X L isoforms, the fact that the molecular weight of the protein detected corresponded to the Bcl-X L isoform at 29 kDa suggests that Tat The antibody used here for p53 detection recognizes both the mutant and wild-type form of p53. Tat-1 cell lysates produced a significant p53 band compared to the SKBR-3 breast carcinoma cell line, a high expressor of mutant p53 protein.
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K562 cell lysates were used as negative controls and displayed no detectable p53 band (Figure 7) . It remains to be further elucidated whether the mutant or wild form of p53 protein is over-expressed in Tat-1 cells.
Discussion
The malignant nature of the new spontaneously transformed Tat-1 cell line was confirmed by the karyotypic, histologic and immunophenotypic analyses. The ability of Tat-1 cells to develop tumorigenic growth in RAG-2 mice leading to death
Figure 5
Interphase and metaphase of the Tat-1 cell line demonstrating MFISH of the c-myc (blue signals), IgH (green signals) and bcl-2 (red signals) DNA probes. In detail, single c-myc copy is detected on der(1)t(1;8)(p34;q22), and normal 8, single IgH copy on normal 14, and single bcl-2 copy on both normal 18. Co-localization IgH/bcl-2 is detected on der(14)t(14;18)(q32;q21). Finally, co-localization c-myc/IgH/bcl-2 (cassette) is detected on der(8)(8pter → 8q24::14q32::18q21 ar 18qter) and der(13)(13pter → 13q24::8q24::14q32::18q21 → 18qter).
Figure 6
Comparative chemosensitivity profiles in the established Tat-1 cell line. (a) Chemosensitivity profiles for Dox in fresh biopsy lymphoma cells (-᭹-) and in the permanent 5-month-old cell culture (-̆-). 2 × 10 5 cells/100 l were plated in 96-well culture plates. Serial Dox concentrations were added in triplicate cultures and the cells were incubated for 72 h after which the MTT assay was performed. IC50 values were calculated using the sigmoidal E max model. in all subcutaneously injected animals confirmed its malignant and invasive characteristics.
Chromosomal analysis had been performed at the time of diagnosis (1994) and again at relapse of disease (1998), allowing comparisons with the karyotype of the established cell line after 4 months in culture (Figure 3) . The initial lymph Leukemia node specimen (1994) revealed a karyotype with t(14;18) and a number of related sidelines. The second analysis at disease transformation 4 years later showed further clonal evolution involving two related sidelines, one of which contained a rearrangement at 8q24. The established cell line had the same karyotype as the sideline with the 8q24 aberration. These fin- dings clearly demonstrated disease progression with likely additional deregulation of the c-myc oncogene. MFISH and FISH analysis revealed co-localization of c-myc, IgH and bcl-2 at two sites, one on the add(8q24) and one on the der (13) .
Recent studies suggest that the abrupt evolution of FL to high-grade lymphoma is frequently associated with chromosomal translocations leading to c-myc activation. [25] [26] [27] In our case, c-myc was translocated to chromosome 1 as well as involved in complex fusions involving IgH and bcl-2. Rearrangements involving c-myc/IgH/bcl-2 conjunctions have been previously demonstrated in diffuse lymphoma cell lines bearing a t(14;18) in which c-myc and bcl-2 become deregulated by the same IgH gene. 28, 29 In this case, MFISH was utilized to demonstrate the co-localization of chromosomal material from 8, 14 and 18, although the limits of this methodology were reached in that not all metaphases showed the small piece of chromosome 14 between the chromatin from 8 and 18 (only seen in extended chromosomes). However, with the more sensitive three-color regional probe FISH unequivocally confirmed the co-localization of all three loci. The structure of this c-myc/IgH/bcl-2 'cassette' at the molecular level has not been further investigated at this time. This type of comprehensive molecular cytogenetic dissection of complex chromosomal rearrangements will facilitate molecular identification of the critical genetic events associated with development and progression of low-grade FL.
The significance of other chromosomal regions commonly disrupted in B cell lymphoma in relation to disease progression and represented in the Tat-1 cells, including 6q16, 8q22, 9q21, 10q22 and 10q24, 12q13, 12q24.1, has yet to be determined. Structural abnormalities of the long arm of chromosome 6 represent recurrent abnormalities in various lymphoid neoplasms including B cell FL and are correlated with tumor progression. 30, 31 Loss of the genetic material on the short arm of chromosome 9 suggests an association between genes located on this site and acute lymphoblastic leukemia. 32 The 10q24 region is believed to be the site of homeobox gene HOX11 and deletions of 10q24 appear to be associated with T cell leukemia lymphoma. 33 In animal experiments we observed that a gradual decrease in the expression of the surface CD20 antigen on the Tat-1 cells grown in mice was accompanied by a gradual decrease in the time that was necessary to establish a tumor. Because CD20 is expressed primarily on mature B lymphocytes, it appears that the cells grown in vivo may have a more immature phenotype than the original cell line. Obviously, the inoculated Tat-1 cells have been forced to pass through selection processes before the cells could efficiently proliferate. This implies that either a CD20-negative subclone of lymphoma cells had been selected for its growth advantage in the mice or that suppression of CD20 had occurred which suggests that CD20 antigen plays an important role in the process of tumor cell engraftment. A detailed phenotypic analysis is required to investigate whether any other surface antigens such as adhesion molecules could account for the tumor growth properties in immunodeficient mice. The cytokine network may be involved in regulating cell growth since Tat-1 cells are shown to be sensitive to some exogenous interleukins (IL-2, IL-4) in suspension culture.
We have made a preliminary estimation of Tat-1 cell sensitivity to Dox, Vin and Cis. Original biopsy tumor cells demonstrated almost two-fold higher resistance to Dox than the established cell line. This may reflect subtle changes in cell growth regulation since markers of known intracellular drug resistance mechanisms did not appear to shift significantly. Of interest is that although the Tat-1 cells express significant amounts of the P-gp protein, the specific inhibitor of Pg-p activity, Val, did not increase cell sensitivity to Dox or Vin as measured by MTT cytotoxicity assay. Moreover, our drug uptake experiments suggest that P-gp protein may not be functioning efficiently in Tat-1 cells. This may reflect the presence of alternative mechanism(s) in Tat-1 cells contributing to the cell survival.
We have also examined the expression of apoptosis-regulating proteins as possible elements in chemosensitivity of Tat-1 lymphoma since apoptosis plays an important role in NHL cell survival and is commonly associated with exposure to the cytotoxic drugs. 34 It is well documented that Bcl-2 protein interacts with other members of an expanding family of apoptosis-regulating proteins, such as Bax, Bcl-X L , Bcl-X s and others. 6, 7, 18, [35] [36] [37] There is also evidence that Bcl-2 protein can be regulated by wild-type or mutant p53 protein in vitro in breast cancer cells as well as in vivo in mice. [38] [39] [40] p53 has also been shown to be a direct transcriptional activator of Bax. 41 Considering the importance of these interactions for the survival of malignant lymphocytes during oncogenesis and chemotherapeutic treatment the Tat-1 cell line represents a good example of co-expression of these proteins and could be used for studies focusing on their role in resistance to druginduced apoptosis.
In conclusion, various factors and molecular mechanisms are involved in the development and transformation of FL into more aggressive forms of disease. The availability of wellcharacterized lymphoma cell lines with specific features will aid molecular and cellular studies designed to identify the biological significance of each step in the multi-grade tumor progression. The Tat-1 cell line described here contains various unique chromosomal abnormalities, expresses a number of apoptosis-regulating proteins and P-gp protein and develops tumor masses in immunodeficient mice. These features could provide a useful tool for studies focused on different aspects of the malignant nature of lymphocytes. Tat-1 cell line will be provided to outside investigators upon a reasonable request. very grateful to Don Philips, Kees Pot and Visia Dragovska for technical assistance in flow cytometric analysis, Dana Masin for animal work assistance and Dr Chris Williams for clinical care of the patient.
